Tripartite motif-containing protein 75 (TRIM75)

TRIM75 is part of the TRIM family, which are structurally defined by the RBCC motif (RING, B-box, coiled-coil domains)[2]. The protein's crystal structure shows a unique tetrameric architecture stabilized by two disulfide bonds in its coiled-coil domain, suggesting a role in the spatial arrangement critical for E3 ligase activity, necessary for transferring ubiquitin from E2 enzymes to substrates[1][3]. This tetrameric assembly is hypothesized to facilitate the dimerization needed for E3 ligase ubiquitin transfer, a process essential in protein degradation and cellular signaling, typical of TRIM family roles[1][2]. While TRIM family proteins—such as TRIM5, TRIM21, and TRIM25—play regulatory roles in immunity, cancer, and several genetic diseases[2], TRIM75 is not individually implicated in any specific diseases, nor is it recognized as a target for approved or experimental drugs in current sources[4]. Its classification as a pseudogene or putative protein in many databases implies uncertain biological relevance, limited functional data, and unsuitability for current drug targeting[4]. Key Points: - **TRIM75** is a putative E3 ubiquitin ligase and member of the TRIM protein family. - No established therapeutic targeting or drug interaction data are available. - Current sources treat TRIM75 as a pseudogene or uncharacterized protein in humans, warranting caution in target validation[4]. - It participates in general TRIM protein structural roles but lacks confirmed unique function, disease association, or established druggability[4][1].

Other names

Tripartite motif-containing protein 75TRIM75TRIM75PTripartite motif-containing protein 75, pseudogenePutative tripartite motif-containing protein 75TRIM75 pseudogene

Not applicable; no drugs reported to target TRIM75 directly